ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.
Arrivent Biopharma stock last closed at $24.10, down 2.09% from the previous day, and has increased 7.33% in one year. It has overperformed other stocks in the Biotechnology industry by 0.59 percentage points. Arrivent Biopharma stock is currently +55.75% from its 52-week low of $15.47, and -11.48% from its 52-week high of $27.22.
There are currently 44.2M AVBP shares outstanding. The market value of AVBP is $1.07B. In the last 24 hours, 436,000 AVBP shares were traded.
How to Buy Arrivent Biopharma Stock
Not sure how to invest in Arrivent Biopharma stock? Here's how.
Choose where to buy Arrivent Biopharma stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you decide where to buy Arrivent Biopharma stock.
Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Fund your brokerage account: Select your method of payment and add your info.
Evaluate Arrivent Biopharma stock: The Arrivent Biopharma ticker symbol is AVBP. Is Arrivent Biopharma stock a good investment? Should you buy shares of AVBP? How do AVBP's underlying business fundamentals look? Do top analysts think Arrivent Biopharma is a good buy? Why has AVBP's stock price moved recently? (Hint: Our stock research tools can help you understand if AVBP is a good stock to buy).
Place your AVBP buy order: Decide if you will purchase AVBP shares at the current market price or use a limit order to purchase AVBP shares at a specific price.
Keep tabs on your AVBP investment: Create a watchlist to monitor your investment in Arrivent Biopharma stock.
Step 1: Choose where to buy Arrivent Biopharma stock
You need an online brokerage account to access the NASDAQ market and buy AVBP shares.
A brokerage account enables you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our experience, eToro is the best brokerage. Here's why:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to global financial markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've selected the right brokerage, you need to fill out some personal information so you can buy AVBP today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Arrivent Biopharma stock
After you have decided on the best place to buy Arrivent Biopharma stock, it's critical to evaluate their stock before you buy, so you truly understand the risk as well as the opportunity.
Arrivent Biopharma shares data
AVBP Price
$24.10
1w %
-4.57%
1y %
7.33%
5y %
N/A
P/E
-5.58x
P/B
3.47x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$166.31M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$1.07B
Next Earnings
Mar 26, 2026
Next Dividend
N/A
AVBP Due Diligence Checks
WallStreetZen was built to help everyday investors do more accurate fundamental analysis in less time.
There are more short-term assets than long-term liabilities on the AVBP balance sheet.
AVBP has a low debt to equity ratio of 0.08.
There are more short-term assets than short-term liabilities on the AVBP balance sheet.
AVBP has cash burn of 160588000. It has enough cash and short-term investments to cover this for at least one year.
Negative Financial Indicators:
AVBP has $312.82M in cash and short term investments. This is not sufficient to cover its annual cash burn of $160.59M.
Do Wall Street analysts think it's a good time to buy Arrivent Biopharma stock
Out of 6 Equities analysts who give forecasts on AVBP, the consensus analyst rating on Arrivent Biopharma is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they financial advice.
Latest AVBP Analyst Upgrades/Downgrades
Asthika Goonewardene, a bottom 8% analyst from Truist Securities initiates coverage on AVBP with a strong buy rating and announces their AVBP price target of $43.00, on Nov 25, 2025.
Over the last year, executives and large shareholders at AVBP have sold more shares than they have bought.
Hillhouse Investment Management Ltd, 10% Owner of AVBP, was the latest AVBP insider to sell. They sold $12,983,320.35 worth of AVBP shares on Dec 10, 2025.
No, Arrivent Biopharma doesn't provide an income stream by paying out dividends.
What others are saying about AVBP
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your AVBP buy order
There are two main order types:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are usually fine.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to be sure you're buying or selling at a specific price, place a limit order.
Hit the Open Trade button and your broker will place the order.
If you require more help with buying stocks on eToro, click the how to video below:
How much does it cost to buy one Arrivent Biopharma share?
As of Mar 12, 2026, it costs $24.10 to buy one share of Arrivent Biopharma stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.415 shares of AVBP.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.